Menopause transition and cardiovascular disease risk

Area of Science:

• Cardiology
• Endocrinology
• Women's Health

Background:

• Cardiovascular disease (CVD) risk increases significantly for women in their fifth decade, coinciding with menopause.
• This increase occurs approximately 10 years later than in men.
• Menopause triggers cardiometabolic changes, including altered body composition, elevated blood pressure, lipoprotein changes, and insulin resistance.

Purpose of the Study:

• To review current literature on cardiovascular disease (CVD) in midlife women.
• To examine cardiometabolic changes associated with ovarian aging versus chronological aging.
• To explore the impact of menopause characteristics (age, type, hormone therapy) on CVD risk.

Main Methods:

• Literature review of current research on menopause and cardiovascular disease.
• Focus on differentiating age-related changes from menopause-specific effects.
• Analysis of studies investigating menopause symptoms and their link to CVD.

Main Results:

• Menopause transition is an independent risk factor for CVD.
• Earlier onset of menopause correlates with a greater CVD risk.
• Menopause-related symptoms like vasomotor symptoms and sleep disturbances may directly impact CVD risk.

Conclusions:

• Menopause significantly impacts cardiovascular health in midlife women.
• Understanding menopause-specific factors is crucial for CVD risk assessment.
• Further research into menopause hormone therapy's role in CVD is warranted.